# Inactivated Hepatitis A Virus Vaccine

## Havrix 720 (Government) 0.5mL/dose

| TAH Drug Code      | [IHAV0](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHAV0)                                     |
|:-------------------|:-----------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against infections caused by hepatitis A virus.                                        |
| Dosing             | IM, 0.5mL, 12 months-15 years primary immunization. A booster dose after 6-36 months.                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                              |
| Contraindications  | Hypersensitivity.                                                                                          |
| Adverse Effects    | Inj site soreness, mild redness & swelling, headache, malaise, vomiting, fever, nausea & loss of appetite. |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/hepatitis-a-vaccine-hepa-drug-information)                    |

## HAVRIX 1440, 1mL/dose (Private)

| TAH Drug Code      | [IHAV1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHAV1)                                     |
|:-------------------|:-----------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against infections caused by hepatitis A virus.                                        |
| Dosing             | IM, 0.5mL, > or = 19 years primary immunization. A booster dose after 6-12 months.                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                              |
| Contraindications  | Hypersensitivity.                                                                                          |
| Adverse Effects    | Inj site soreness, mild redness & swelling, headache, malaise, vomiting, fever, nausea & loss of appetite. |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/hepatitis-a-vaccine-hepa-drug-information)                    |

